Skip to main content
Clinical Trials/PACTR201909641727181
PACTR201909641727181
Recruiting
Phase 3

Efficacy of midazolam and dexmedetomidine for attenuating the hormonal stress response to endotracheal intubation in hypertensive adult patients undergoing elective surgery.

eman sayed0 sites40 target enrollmentSeptember 14, 2019
ConditionsAnaesthesia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anaesthesia
Sponsor
eman sayed
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
eman sayed

Eligibility Criteria

Inclusion Criteria

  • ASA physical status II \& III, aged 18–65 years, scheduled for elective surgery, and known to be hypertensive with good control ( blood pressure lower than 140/90\), were included in the study.

Exclusion Criteria

  • Patients were excluded if they have known allergy to any of the study drugs, arterial blood pressure more than 140/90, preoperative arrhythmias, tachycardia (heart rate \> 100 beats per minute), bradycardia (heart rate \< 50 beats per minute), second\- or third\-degree atrioventricular block, coronary artery disease, , previous cerebrovascular accident, renal or liver impairment, obesity (body mass index\>30\), and suspected difficult intubation.

Outcomes

Primary Outcomes

Not specified

Similar Trials